This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers, clinicians and innovators. The series will help attendees anticipate, access, and apply new approaches and technologies for patient care.
The Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
We are pleased to share that as of the 2026/2027 season, the Garrod Association will be providing two presentations per season.
To register, click the button below or go to: https://us06web.zoom.us/webinar/register/WN_e2yO6xnsSK2v70BLslqwjA
2025-2026 Leading Strand from 12:00pm – 1:00pm ET on:
Friday September 26, 2025
Neurotransmitter Disorders – Updates
This session will provide an introduction to monoamine and amino acid neurotransmitter disorders, and updates on novel diagnoses and therapies.
Learning Objectives:
- Assess patients presenting with symptoms of neurotransmitter disorders.
- Diagnose and treat patients with monoamine and amino acid neurotransmitter deficiencies.
Speaker: Dr. Gabriella Horvath
Bio: Dr. Gabriella Horvath is a Biochemical Geneticist, Clinical Professor at the University of British Columbia, Department of Pediatrics, Division of Biochemical Genetics. She works both in the Pediatric and adult metabolic clinics, and has special interest in neurometabolic disorders.
